Eero Vasar Selected Research

Eero Vasar Research Topics

Disease

10	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 12/2015
10	Wolfram Syndrome (Syndrome, Wolfram) 11/2021 - 08/2008
8	Schizophrenia (Dementia Praecox) 01/2022 - 03/2014
8	Vitiligo 05/2016 - 11/2007
5	Mental Disorders (Mental Disorder) 01/2019 - 01/2013
4	Inflammation (Inflammations) 12/2021 - 12/2015
4	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2021 - 02/2005
4	Glucose Intolerance 10/2019 - 09/2011
3	Body Weight (Weight, Body) 01/2020 - 03/2009
3	Major Depressive Disorder (Major Depressive Disorders) 01/2019 - 12/2008
2	Disease Progression 01/2022 - 11/2021
2	Neuroinflammatory Diseases 01/2022 - 10/2019
2	Atrophy 01/2021 - 01/2017
2	Hypoglycemia (Reactive Hypoglycemia) 10/2020 - 01/2017
2	Hypoxia (Hypoxemia) 01/2018 - 04/2014
2	Hypothermia 01/2018 - 04/2014
2	Seizures (Absence Seizure) 01/2018 - 02/2004
2	Mood Disorders (Mood Disorder) 01/2016 - 12/2011
2	Hyperalgesia 03/2008 - 09/2004
2	Pain (Aches) 09/2004 - 03/2003
1	Obesity 01/2022
1	Sensorineural Hearing Loss 11/2021
1	Intellectual Disability (Idiocy) 06/2021
1	Autistic Disorder (Autism) 06/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Cognitive Dysfunction 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Diabetes Mellitus 10/2019
1	Hyperglycemia 03/2019
1	Necrosis 01/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019
1	Gliosis 01/2017

Drug/Important Bio-Agent (IBA)

10	Polytetrafluoroethylene (Teflon)FDA Link 01/2022 - 12/2015
9	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 12/2015
7	Messenger RNA (mRNA)IBA 12/2021 - 02/2005
5	Glucose (Dextrose)FDA LinkGeneric 10/2020 - 03/2009
4	Liraglutide FDA Link 11/2021 - 01/2018
4	Insulin (Novolin)FDA Link 03/2019 - 01/2017
4	InterleukinsIBA 01/2019 - 01/2010
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 08/2008
4	Interleukin-10 (Interleukin 10)IBA 04/2012 - 02/2005
3	MelanocortinsIBA 12/2021 - 11/2007
3	EnzymesIBA 12/2021 - 10/2008
3	Amino Acids FDA Link 01/2020 - 01/2016
3	Glucagon-Like Peptide-1 ReceptorIBA 10/2019 - 01/2016
3	AntioxidantsIBA 01/2018 - 04/2014
3	CytokinesIBA 05/2016 - 04/2012
3	limbic system-associated membrane proteinIBA 01/2015 - 01/2013
3	Melanocortin Receptors (Melanocortin Receptor)IBA 07/2013 - 11/2007
3	Cholecystokinin (Pancreozymin)IBA 03/2008 - 03/2003
2	LipidsIBA 01/2022 - 02/2020
2	LipopolysaccharidesIBA 01/2022 - 01/2020
2	Opioid Analgesics (Opioids)IBA 12/2021 - 09/2004
2	Hypoglycemic Agents (Hypoglycemics)IBA 10/2020 - 01/2017
2	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2020 - 01/2016
2	Biogenic Amines (Biogenic Amine)IBA 01/2020 - 01/2018
2	Hormones (Hormone)IBA 04/2019 - 07/2013
2	Adrenocorticotropic Hormone (ACTH)FDA Link 04/2019 - 07/2013
2	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 04/2019 - 07/2013
2	Pharmaceutical PreparationsIBA 01/2019 - 01/2014
2	Pentylenetetrazole (Metrazol)IBA 01/2018 - 02/2004
2	Epidermal Growth Factor (EGF)IBA 01/2016 - 12/2015
2	RNA (Ribonucleic Acid)IBA 04/2014 - 11/2007
2	Valproic Acid (Depakote)FDA LinkGeneric 01/2014 - 09/2011
2	Cholecystokinin B ReceptorIBA 12/2009 - 09/2004
1	EndocannabinoidsIBA 01/2022
1	N-acylethanolaminesIBA 01/2022
1	anandamide (arachidonylethanolamide)IBA 01/2022
1	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 01/2022
1	linoleoyl ethanolamideIBA 01/2022
1	oleoylethanolamideIBA 01/2022
1	CannabinoidsIBA 01/2022
1	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2022
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2022
1	palmidrolIBA 01/2022
1	SolutionsIBA 11/2021
1	Cell Adhesion MoleculesIBA 06/2021
1	Pioglitazone (Actos)FDA Link 01/2021
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021
1	6,7-dihydroxyflavoneIBA 01/2021
1	acylcarnitineIBA 02/2020
1	Neuroprotective AgentsIBA 10/2019
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2019
1	Plasminogen Activator Inhibitor 1IBA 01/2019
1	Ferritins (Ferritin)IBA 01/2019
1	ResistinIBA 01/2019
1	AdiponectinIBA 01/2019
1	C-PeptideIBA 01/2019
1	LeptinIBA 01/2019
1	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Protein Isoforms (Isoforms)IBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Glucagon (Glukagon)FDA Link 01/2018
1	Retinaldehyde (Retinal)IBA 01/2017
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2017
1	Iodide Peroxidase (Deiodinase)IBA 05/2016
1	AntibodiesIBA 05/2016

Therapy/Procedure

1	Induced Hypothermia 01/2018